Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
SAJE Pharma Logo
SAJE Pharma Growth Score
81
CB Rank
315881
Heat Score
25
SAJE Pharma is a bio-pharmaceutical company developing therapeutic agents for respiratory diseases.
Founded
obfuscation
PrivateSeed Baltimore, Maryland, United States1-10 sajepharma.com
Biopharma
Biotechnology
Therapeutics
Overview

SAJE Pharma
Total Funding
obfuscation
Growth Score
81
Heat Score
25

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score81
-9 pts
in past quarter
Heat Score 25
-16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About SAJE Pharma

CB Rank
315881
SAJE Pharma is a bio-pharmaceutical company developing therapeutic agents for respiratory diseases.
Founded
obfuscation
PrivateSeed Baltimore, Maryland, United States1-10 sajepharma.com
Biopharma
Biotechnology
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name SAJE Pharma LLC
Operating Status Active
Company Type For Profit
Founders  Helen S. Pentikis, Matthews O. Bradley
About the Company

SAJE Pharma LLC, a biopharmaceutical company, develops therapeutic agents for respiratory diseases. It develops lead molecules that pharmacologically regulate the levels of nitrosylated proteins and show safety in animals and efficacy in molecular, cellular, organ culture, and animal models of disease. The company develops agents for asthma and

chronic obstructive pulmonary diseases, and cardiovascular diseases. The company was incorporated in 2009 and is based in Baltimore, Maryland.

Phone Number 4434517421
Contact Email hpentikis@sajepharma.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

SPL-850
SPL-850 is a small molecule inhibitor of S-nitrosoglutathione reductase (GSNOR) that increases cellular levels of S-nitrosoglutathione (GSNO) to regulate nitrosylation and provide multi-mechanism therapeutic effects for inflammatory, oxidant-based, mitochondrial, and fibrotic diseases.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - SAJE Pharma Logo
Seed Round - SAJE Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - SAJE Pharma Logo
Seed Round - SAJE Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - SAJE Pharma Logo
Seed Round - SAJE Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - SAJE Pharma Logo
Seed Round - SAJE Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - SAJE Pharma Logo
Seed Round - SAJE Pharma
—
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - SAJE Pharma Logo
Seed Round - SAJE Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - SAJE Pharma Logo
Seed Round - SAJE Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - SAJE Pharma Logo
Seed Round - SAJE Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - SAJE Pharma Logo
Seed Round - SAJE Pharma
—
obfuscation
— Seed
obfuscation
Seed Round - SAJE Pharma Logo
Seed Round - SAJE Pharma
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2

Employee Profiles

News
Technology
View Tech Report

IT Spend

$92.4KThis year, SAJE Pharma is projected to spend $92.4K on IT, according to Aberdeen.

Actively Used Products

6SAJE Pharma uses 6 technology products and services including HTML5, GoDaddy, and  GoDaddy Premium DNS, according to G2 Stack.

Active Website Tech Count

3SAJE Pharma is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.

Total IP

1SAJE Pharma has 1 registered patent in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is SAJE Pharma's headquarters? SAJE Pharma is located in Baltimore, Maryland, United States.When was the last funding round for SAJE Pharma? SAJE Pharma closed its last funding round on
obfuscation
from a Seed round.Who are SAJE Pharma's competitors? Alternatives and possible competitors to SAJE Pharma may include AstraZeneca, Boehringer Ingelheim, and  GSK.How much funding has SAJE Pharma raised to date? SAJE Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|